8-K current report · filed Jul 20, 2026

NEOGENOMICS INC (NEO) 8-K Current Report: July 20, 2026

Item 8.01Item 7.01NEO overview

Short answer

NEOGENOMICS INC (NEO) filed an 8-K current report with the SEC on July 20, 2026 reporting Item 8.01 (Other Events), Item 7.01 (Regulation FD Disclosure). June 20, 2026 press release announces information related to the settlement agreement.

NEOGENOMICS INC 8-K event analysis

AI summary of each reported item and its exhibits

Item 7.01 · Regulation FD Disclosure

  • June 20, 2026 press release announces information related to the settlement agreement
  • Settlement details appear under Item 8.01 and may affect NeoGenomics’ legal and financial outlook

Item 8.01 · Other Events

  • $9.813M civil settlement with DOJ resolving investigation into consulting services for healthcare providers
  • Settlement follows voluntary 2021 OIG-HHS notification concerning federal healthcare-law compliance
  • $11.2M reserve previously accrued as of March 31, 2026, exceeding the settlement payment
  • Agreement includes neither company admission of liability nor government concession on claim merits

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other NEOGENOMICS INC 8-K filings

Get the next NEO 8-K as it lands

Follow NEO for push alerts, or ask the research agent what this filing means.